- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04263545
The Staff Stop Smoking Project (STOP)
February 7, 2020 updated by: Portsmouth Hospitals NHS Trust
A Randomised Feasibility Study Comparing a Novel Intervention for Smoking Cessation in NHS Staff to Standard Care
Participants will be randomised to either standard care or to receive our help to quit programme.
The study will only be available to Portsmouth Hospital Trust staff member.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A randomised controlled feasibility study to trial a novel intervention to help NHS staff stop smoking compared to standard care.
Participants will attend one-on-one interviews and a support group where they will undertake CO monitoring and mini-spirometry.
They will complete questionnaires about their quality of life, other health problems and their general state of health.
They will attend the support groups on a weekly basis and have access to support outside of these times.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Portsmouth, United Kingdom, PO6 3LY
- Portsmouth Hospitals NHS Trust
-
-
Hampshire
-
Portsmouth, Hampshire, United Kingdom, PO6 3LY
- Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or Female, aged 18 years or over
- Willing and able to give informed consent for participation in the study.
- Must work for PHT at QAH and be able to attend weekly meetings for the duration of the study period
- Must be a current smoker
Exclusion Criteria:
-Unable to comprehend the study and provide informed consent e.g. insufficient command of English in the absence of someone to adequately interpret.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Intervention
|
Group session with smoking cessation counsellor
|
|
PLACEBO_COMPARATOR: Standard Care
|
standard care arm will receive very brief advice (VBA) and signposting to local organisations to support a quit.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioural outcomes
Time Frame: 4 weeks
|
Number of smokers who achieve a successful quit
|
4 weeks
|
|
Behavioural outcomes
Time Frame: 12 weeks
|
Number of smokers who achieve a successful quit
|
12 weeks
|
|
Behavioural outcomes
Time Frame: 6 months
|
Number of smokers who achieve a successful quit
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 3, 2019
Primary Completion (ACTUAL)
June 21, 2019
Study Completion (ACTUAL)
June 21, 2019
Study Registration Dates
First Submitted
January 29, 2020
First Submitted That Met QC Criteria
February 7, 2020
First Posted (ACTUAL)
February 10, 2020
Study Record Updates
Last Update Posted (ACTUAL)
February 10, 2020
Last Update Submitted That Met QC Criteria
February 7, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- PHT/2019/17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
Clinical Trials on Group session with smoking cessation counsellor
-
University of OsloCharles University, Czech Republic; The Research Council of NorwayRecruitingNicotine Dependence, CigarettesCzechia, Norway
-
Memorial University of NewfoundlandCompletedSmoking Cessation | Quality of Life | Smoking, TobaccoCanada
-
University of MontanaPrevent Cancer FoundationCompletedRandomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking CessationSmoking | Tobacco Use DisorderUnited States
-
London South Bank UniversityNHS Lambeth; NHS Southwark CCG; Allen Carr EasywayCompleted
-
Assiut UniversityNot yet recruiting
-
Glostrup University Hospital, CopenhagenUniversity of Aarhus; Rygestopkonsulenterne, HillerødCompleted
-
University of OsloCharles University, Czech Republic; The Research Council of NorwayRecruiting
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingCigarette Smoking-Related CarcinomaUnited States
-
Charite University, Berlin, GermanyProf. Dr. Felix Bermpohl, Co-PICompletedHealthy | Tobacco Use DisorderGermany
-
Shanghai Jiao Tong University School of MedicineNot yet recruitingSmoking Cessation | Hypertension